Federal health authorities and medical professionals are urging older adults to schedule enhanced influenza immunizations this fall, pointing to elevated risks of hospitalization and severe disease among seniors.
As people age, immune defenses naturally decline, leaving individuals 65 and older responsible for the majority of severe flu complications and fatalities, Your Ohio News reported. Because of that vulnerability, the Centers for Disease Control and Prevention advises people in that age bracket to select one of three enhanced vaccines rather than a standard-dose shot: Fluzone High-Dose, Fluad, or Flublok.
Choosing the right shot
Each of the three enhanced options utilizes a distinct formulation—such as higher antigen concentrations or added adjuvants—to trigger a sturdier immune defense in aging bodies. Research indicates that none of the three holds a clear clinical advantage over the others, meaning older individuals do not need to delay vaccination to locate a particular brand, according to Your Ohio News.
The 2026–2027 season also features Moderna’s mFLUSIVA, which marks the first messenger RNA flu vaccine cleared in the United States. While regulators granted standard approval for people ages 50 to 64 and accelerated approval for those 65 and older, public health guidance still instructs seniors to prioritize the three established enhanced options whenever they are available.
For the broader population, age remains the fundamental metric determining which shot is appropriate, Adam James, a pharmacist managing clinical immunization programs, told Pharmacy Times. Adults younger than 65 typically receive standard formulations, while people between ages 2 and 50 who prefer to bypass needles can select nasal spray options, James explained.
Timing and concurrent vaccines
Health officials pinpoint September and October as the best window to roll up a sleeve, though getting vaccinated later still provides valuable protection. Flu activity regularly extends through February, March, and occasionally into April, making late-season shots worthwhile, James noted.
Older adults can also utilize their appointment to review additional routine immunizations. Healthcare providers frequently recommend a one-time respiratory syncytial virus shot for anyone 75 and older, as well as for adults ages 50 to 74 who face heightened risk. Pneumococcal immunizations, such as Prevnar 20 or Capvaxive, are suggested for adults 50 and older who have not yet received them. Providers also evaluate patient needs for the two-dose Shingrix shingles vaccine and updated COVID-19 formulations.
Medicare Part B covers the annual flu vaccine, pneumococcal shots, and COVID-19 immunizations at no out-of-pocket cost through participating providers, while Medicare Part D covers RSV and shingles inoculations, Your Ohio News reported.
Atypical symptoms in older adults
Physicians warn that influenza does not always manifest identically across age groups. While younger patients commonly experience classic symptoms such as sudden fevers, chills, and body aches, older adults may never develop a noticeable fever, Banner Health reported.
Instead, infection in seniors might appear as sudden confusion, severe fatigue, dizziness, dehydration, or unexpected falls, said Dr. Romana Zar, a geriatric medicine specialist at Banner Health. Chronic conditions like asthma, diabetes, or heart disease can also suddenly deteriorate under the strain of infection.
“Because older adults are at higher risk for severe influenza and complications, they should contact a provider promptly, especially those who have underlying lung disease like asthma or COPD or a history of heart problems,” Zar told Banner Health.
When illness strikes, physicians can prescribe antiviral drugs to curb viral replication and reduce the probability of dangerous outcomes. Because these treatments function most effectively when initiated within 48 hours of initial symptoms, clinicians advise patients to seek medical evaluation immediately rather than waiting for signs of illness to resolve on their own.
